FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/09/2023
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the stylized wording "CPO" to the right of a stylized concentric oval and circle design.
Titulares
Representantes
Jennifer A. Visintine Thompson Coburn LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines in tablet form for the treatment of nutritional and vitamin deficiencies; medicated preparations in the form of powders, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; veterinary preparations in the form of powder, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of veterinary pharmaceuticals; veterinary preparations, namely, dietary and nutritional supplements for veterinary use; medical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and minerals; medicated supplements for foodstuffs for animals; medicated supplements for foodstuffs for human consumption for medical purposes; medicated skin care preparations; medicated preparations for use as supplements for food for medical purposes; powders for skin care for medical use; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicinal oils containing vitamins and minerals; oils adapted for pharmaceutical purposes, namely, for the increasing the bioavailability and absorption of active ingredients in foodstuffs and medicines; oils for use in medicine, namely, medicated oils containing vitamins and minerals; dietary supplements; pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; dietetic foods adapted for medical purposes; dietetic substances namely foods, beverages and supplements adapted for medical use; dietetic substances, namely foods, beverages and supplements for veterinary use; dietary supplements; dietary supplements for animals; nutritional meal replacements, namely beverages and supplements adapted for medical use; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients; nutritional supplements; medicinal healthcare products, namely, dietary supplements with medicinal properties that increase the bioavailability and absorption of active ingredients in foodstuffs and medicines; chemical products for use in medical or veterinary biotechnology, namely, chemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicines; biotechnological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of nutritional deficiencies; chemical products for medical use, namely, chemical reagents for medical purposes; dietary supplements with a cosmetic effect; medicated skin creams for personal care; medicated preparations for the regeneration of the skin; medicated preparations for the treatment of the skin; medicated preparations for use in the bath; medicated creams for the face
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
12/09/2023
FINAL DISPOSITION NOTICE SENT TO IB
17/08/2023
FINAL DISPOSITION PROCESSED
17/08/2023
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/08/2023
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/05/2023
REGISTERED-PRINCIPAL REGISTER
16/05/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2023
PUBLISHED FOR OPPOSITION
28/02/2023
NOTIFICATION PROCESSED BY IB
27/02/2023
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2023
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/02/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
26/01/2023
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/01/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
18/01/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/01/2023
TEAS REQUEST FOR RECONSIDERATION RECEIVED
18/01/2023
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/01/2023
NEW REPRESENTATIVE AT IB RECEIVED
17/09/2022
NOTIFICATION OF FINAL REFUSAL EMAILED
28/07/2022
FINAL REFUSAL E-MAILED
28/07/2022
FINAL REFUSAL WRITTEN
28/07/2022
TEAS/EMAIL CORRESPONDENCE ENTERED
14/07/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/07/2022
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/07/2022
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/07/2022
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/07/2022
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/07/2022
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/07/2022
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/07/2022
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/07/2022
REFUSAL PROCESSED BY IB
30/01/2022
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/01/2022
REFUSAL PROCESSED BY MPU
13/01/2022
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/12/2021
NON-FINAL ACTION WRITTEN
21/12/2021
ASSIGNED TO EXAMINER
17/12/2021
APPLICATION FILING RECEIPT MAILED
24/08/2021
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/08/2021
LIMITATION FROM ORIGINAL APPLICATION ENTERED
16/08/2021
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/08/2021
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.